OAC Risk Similar With SGLT2i and DPP4i in T2DM Tags DPP-4 inhibitors SGLT-2 Inhibitor Read more about OAC Risk Similar With SGLT2i and DPP4i in T2DM
Empagliflozin Increases Lower UTI Risk Without Altering HF Outcomes Tags TPHT_others Heart Failure Read more about Empagliflozin Increases Lower UTI Risk Without Altering HF Outcomes
AF Incidence Varies by Socioeconomic Deprivation and Genetic Risk Tags Atrial Fibrillation Read more about AF Incidence Varies by Socioeconomic Deprivation and Genetic Risk
Plaque Rupture More Frequent in ACS Patients With Cancer History Tags Acute Coronary Syndrome Read more about Plaque Rupture More Frequent in ACS Patients With Cancer History
β-Blockers Show No Significant Outcome Differences After MI With LVEF >40% Tags Heart Failure Myocardial Infarction TPHT_others Read more about β-Blockers Show No Significant Outcome Differences After MI With LVEF >40%
Higher Postoperative LGI Marks Prolonged Ventilation After AVSD Repair Tags Atrial Septal Defect Percutaneous Coronary Intervention ventricular septal defect Read more about Higher Postoperative LGI Marks Prolonged Ventilation After AVSD Repair
GLP-1 RAs Show Greater HbA1c Improvement vs DPP-4 Inhibitors Tags DPP-4 inhibitors GLP-1 agonists hBA1c Read more about GLP-1 RAs Show Greater HbA1c Improvement vs DPP-4 Inhibitors
MACE, Hypoglycemia Risks Differ Among Sulfonylureas Tags Coronary artery disease Hypoglycemia Sulphonylureas Read more about MACE, Hypoglycemia Risks Differ Among Sulfonylureas
Higher HbA1c Variability Linked to Mortality Risk in T2DM Tags Diabetic Nephropathy Diabetic Neuropathy Myocardial infarction hBA1c Read more about Higher HbA1c Variability Linked to Mortality Risk in T2DM
Dose Escalation Linked to GI Tolerance With Incretins Tags GLP-1 agonists Read more about Dose Escalation Linked to GI Tolerance With Incretins